Postoperative Analgesic Efficacy of Tetracaine Hydrochloride Gel

Topical Anesthesia of Tetracaine Hydrochloride Jelly on Cervix After Hysteroscopic Uterine Stent Insertion

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT02863679

Enrollment

Registered

2016-08-11

Start date

2016-05-31

Completion date

2016-09-30

Last updated

2016-10-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hysteroscopy

Keywords

tetracaine hydrochloride gel, analgesia, intrauterine balloon, hysteroscope operation

Brief summary

This study was taken out to assess the postoperative analgesic efficacy of tetracaine hydrochloride gel in patients with intrauterine adhesion treating with intrauterine balloon.Participates were assigned into two groups by randomly-tetracaine hydrochloride gel group and control group.

Detailed description

Tetracaine hydrochloride gel contains 1% tetracaine hydrochloride, and a fair dose of fungicide, lubricants, remove foam agent, as the long-term local anesthetics. Patients in getracaine hydrochloride gel group were covered with a gauze of tetracaine hydrochloride gel on the external cervical orifice after insert an utrauterine balloon in the uterine cavity. While patients in the control group were covered with a blank gauze after hysteroscopic adhesiolysis. Compare the postoperative analgesic scor and patients' analgesic satisfaction of the two groups and asess the analgesic efficacy of tetracaine hydrochloride gel.

Interventions

DRUGTetracaine hydrochloride gel

Tetracaine hydrochloride gel contains 1% tetracaine hydrochloride, and a fair dose of fungicide, lubricants, remove foam agent, as the long-term local anesthetics.

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender

FEMALE

Age

19 Years to 40 Years

Healthy volunteers

Inclusion criteria

* no previous history of hysteroscopic adhesiolysis or surgery on the cervix * inserted intrauterine balloon in the uterine cavity after hysteroscopic adhesiolysis * no other diseases

Exclusion criteria

* Allergy to local anesthetics * Patients with chronic pain * Patients with abnormal blood coagulation function * Patients with mental illness that can not cooperate * Patients with previous hysteroscopic adhesiolysis or cervical surgery

Design outcomes

Primary

Measure	Time frame
Numerical Rating Scale (NRS) score	7 days

Secondary

Measure	Time frame
patients received balloon volume reduction	1 day

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026